Concomitant Expression of Inhibitory Molecules for T cell Activation Predicts Poor Survival in Patients with Esophageal Squamous Cell Carcinoma - Chen, Zhijun; Cao, Kexin; Zhang, Jinghang; Liu, Zhuangzhuang; Lu, Liaoxun; Qi, Bo; Shi, Lijin; Huang, Rong; Zhao, Song (Current cancer drug targets, 2021)
Keywords: Adult; Aged; Antigens, CD - metabolism; Biomarkers, Tumor - metabolism; CTLA-4 Antigen - metabolism; Esophageal Neoplasms - immunology; Esophageal Neoplasms - metabolism; Esophageal Neoplasms - mortality; Esophageal Neoplasms - pathology; Esophageal Squamous Cell Carcinoma - immunology; Esophageal Squamous Cell Carcinoma - metabolism; Esophageal Squamous Cell Carcinoma - mortality; Esophageal Squamous Cell Carcinoma - pathology; Female; Follow-Up Studies; Hepatitis A Virus Cellular Receptor 2 - metabolism; Humans; Kaplan-Meier Estimate; Lymphocyte Activation - immunology; Lymphocyte Activation Gene 3 Protein; Male; Middle Aged; Prognosis; Programmed Cell Death 1 Receptor - metabolism; Receptors, Immunologic; Survival Rate; T-Lymphocytes - immunology; T-Lymphocytes - metabolism; BTLA; T cells; TIM-3; PD-1; ESCC; survival